Similar articles

• Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.

  Garraud O, Burnouf T. Garraud O, et al. Transfus Clin Biol. 2021 Aug;28(3):225-227. doi: 10.1016/j.tracli.2021.07.005. Transfus Clin Biol. 2021. PMID: 34362557 Free PMC article. No abstract available.
• Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.

  Patel MM, Thornburg NJ, Stubblefield WB, Talbot HK, Coughlin MM, Feldstein LR, Self WH. Patel MM, et al. JAMA. 2020 Nov 3;324(17):1781-1782. doi: 10.1001/jama.2020.18796. JAMA. 2020. PMID: 32940635 Free PMC article.
• New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.

  Seghatchian J. Seghatchian J. Transfus Apher Sci. 2021 Feb;60(1):103051. doi: 10.1016/j.transci.2021.103051. Epub 2021 Jan 11. Transfus Apher Sci. 2021. PMID: 33461918 Free PMC article. No abstract available.
• Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.

  Hosseini P, Rahimi H, Najafabadi MM, Ghorbani A, Najafabadi SK, Faridzadeh A, Arabpour J, Khormali E, Deravi N. Hosseini P, et al. Acta Med Indones. 2021 Jan;53(1):86-95. Acta Med Indones. 2021. PMID: 33818411 Review.
• An overview of Covid-19 pandemic: immunology and pharmacology.

  Arif A, Ansari S, Ahsan H, Mahmood R, Khan FH. Arif A, et al. J Immunoassay Immunochem. 2021 Sep 3;42(5):493-512. doi: 10.1080/15321819.2021.1904414. Epub 2021 Mar 31. J Immunoassay Immunochem. 2021. PMID: 33788668 Review.